The aim of this study was to examine the effects of sotagliflozin added to insulin on blood sugar levels in patients with type 1 diabetes (T1D). The main finding of the study was that sotagliflozin and insulin together improved blood sugar control in T1D.

The aim of this study is to evaluate the effect of the DASH (dietary approaches to stop hypertension) diet on heart disease, blood pressure and diabetes in patients with and without diabetes. The main finding of this study was that the DASH diet is associated with a decreased risk of heart disease and improves blood pressure in patients with and without diabetes.

This trial is comparing the effectiveness of G-Pen (Glucagon Injection) to GlucaGen® Hypokit® (Glucagon) in the treatment of hypoglycemia in patients with type 1 diabetes (T1D). The main outcome to be measured is the number of patients with an increase in blood sugar levels within 30 minutes after rescue medication. 

The aim of this study was to investigate if reducing basal insulin rate (BRR) 90-minutes before exercise was better at preventing hypoglycemia (dangerously low blood glucose) than suspending the insulin pump (pump suspension; PS) in type 1 diabetes (T1D). The main finding was that BRR 90-minutes before exercise improved blood glucose control and reduced hypoglycemia compared to PS.

The aim of the study was to look at the relationship between insulin dose and risk of cardiovascular disease (CVD) in type 1 diabetes (T1D). The main finding of the study was that higher insulin doses are associated with CVD risk factors but not with increased CVD events.

The aim of this study was to investigate the relationship between the use of incretin-based anti-diabetic drugs and the risk of hospitalization due to heart failure. The main finding of the study was that the use of these drugs is not associated with an increased risk of hospitalization due to heart failure.

The aim of this study was to investigate if optimal blood glucose control reduces the stiffening (calcification) of the arteries of the heart in patients with diabetes. The main finding of the study was that optimal blood sugar control stopped the calcification of the arteries of the heart.

The aim of this study was to compare three different times to decrease basal insulin to reduce hypoglycemia after exercise in patients with type 1 diabetes. The main finding of the study was that reducing basal insulin by 80% up to 40 minutes before exercise still did not reduce exercise-induced hypoglycemia.

The aim of this study was to investigate the association between the day-to-day self-monitored blood glucose level differences and the risk of hypoglycemia in insulin-treated patients with type 1 and type 2 diabetes. The study found that bigger differences in day-to-day blood glucose levels were associated with a higher risk of hypoglycemia in these patients.

This study examined the association between type 1 diabetes and cancer. The study concluded that type 1 diabetes is associated with differences in the risk of several common cancers.